Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Liew, Su May ^a   Lee, Ping Yein ^b   Hanafi, Nik Sherina ^a   Ng, Chirk Jenn ^a   Wong, Stalia Siew Lee ^a   Chia, Yook Chin ^a   Lai, Pauline Siew Mei ^a   Zaidi, Nur Farhana Mohd ^a   Khoo, Ee Ming ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Diabetes mellitus; HbA1c; Hypertension; Statin

Indexed keywords

ACARBOSE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; DEMOGRAPHY; DIABETES MELLITUS; DRUG USE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84899924992     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-53     Document Type: Article

References (12)

1. U.S. Food and Drug Administration, FDA Drug Safety Communication: Important Safety Label Changes to Cholesterol-Lowering Statin Drugs http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm
2. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, N Engl J Med 2008 359 2195 2207 10.1056/NEJMoa0807646 18997196
3. High-dose atorvastatin associated with worse glycemic control: a PROVE-IT TIMI 22 substudy. Sabatine MS, Wiviott SD, Morrow DA, McCabe CH, Cannon CP, Circulation 2004 110 Suppl I 834
4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, et al. Lancet 2010 375 735 742 10.1016/S0140-6736(09)61965-6 20167359
5. Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM, Diabetes Care 2009 32 1924 1929 10.2337/dc09-0738 19794004
6. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y, Arch Intern Med 2012 172 2 144 152 10.1001/archinternmed.2011.625 22231607
7. International Diabetes Federation, IDF Diabetes Atlas Brussels: International Diabetes Federation 3 2006
8. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, BMJ 2000 321 405 412 10.1136/bmj.321.7258.405 10938048
9. Effects of rosuvastatin and atorvastatin on glycaemic control in type 2 diabetes-the CORALL study. Simsek S, Schalkwijk CG, Wolffenbuttel BH, Diabet Med 2012 29 628 631 10.1111/j.1464-5491.2011.03553.x 22151023
10. Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus. Takano T, Yamakawa T, Takahashi M, Kimura M, Okamura A, J Atheroscler Thromb 2006 13 95 100 10.5551/jat.13.95 16733297
11. theheart.org's statin safety survey draws mixed response. O'Riordan M, http://www.medscape.com/viewarticle/791177
12. Are statins diabetogenic? Sampson UK, Linton MF, Fazio S, Curr Opin Cardiol 2011 26 4 342 347 10.1097/HCO.0b013e3283470359 21499090